Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Parexel Intl Cp (PRXL) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,128,900
  • Shares Outstanding, K 53,410
  • Annual Sales, $ 2,426 M
  • Annual Income, $ 155 M
  • 36-Month Beta 0.87
  • Price/Sales 1.29
  • Price/Book 4.55

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.16 +18.10%
on 11/11/16
61.13 -1.16%
on 11/10/16
+4.02 (+7.13%)
since 11/04/16
3-Month
51.16 +18.10%
on 11/11/16
71.10 -15.02%
on 10/10/16
-4.85 (-7.43%)
since 09/06/16
52-Week
51.16 +18.10%
on 11/11/16
71.13 -15.06%
on 08/30/16
-6.35 (-9.51%)
since 12/04/15

Most Recent Stories

More News
PAREXEL International to Participate in Evercore ISI MedTools Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston. Josef von Rickenbach, Chairman and Chief Executive...

EQUITY ALERT: Lundin Law PC Announces an Investigation of PAREXEL International Corporation and Advises Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 14, 2016 / Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against PAREXEL International Corporation ("PAREXEL" or the "Company")...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PAREXEL International Corporation (PRXL)

Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of PAREXEL International Corporation ("PAREXEL" or the "Company") (NASDAQ:...

PAREXEL Launches IDMP-Focused Software and Service Solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for...

EQUITY ALERT: Goldberg Law PC Announces an Investigation of Claims against PAREXEL International Corporation and Advises Investors with Losses to Contact the Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating PAREXEL International Corporation ("PAREXEL" or the "Company") (Nasdaq: PRXL) concerning...

Glancy Prongay & Murray LLP Commences Investigation on Behalf of PAREXEL International Corporation Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of PAREXEL International Corporation ("PAREXEL" or the "Company") (NASDAQ: PRXL) investors concerning...

Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in PAREXEL International Corp.

Wolf Popper LLP is investigating potential claims on behalf of investors in PAREXEL International Corp. (NASDAQ: PRXL), resulting from PAREXEL's disclosure that it will delay the release of its Form 10-Q...

INVESTOR ALERT: Lundin Law PC Announces an Investigation of PAREXEL International Corporation and Advises Investors with Losses to Contact the Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against PAREXEL International Corporation ("PAREXEL" or the "Company") (Nasdaq: PRXL) concerning...

Downgrade Alert for Parexel International (PRXL)

Parexel International (NASDAQ:PRXL) was downgraded from Outperform to Neutral at Baird today. The stock closed yesterday at $57.73 on volume of 3.0 million shares, above average daily volume of 446,000....

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With...

See More

Support & Resistance

2nd Resistance Point 61.13
1st Resistance Point 60.54
Last Price 60.59
1st Support Level 58.93
2nd Support Level 57.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.